Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
InspireMD, Inc. (NSPR)
USD0.72
+0.00 (+0.33%)
IL NASDAQ Healthcare Medical - Devices
Address
4 Menorat Hamaor Street 6744832
Miami, IL
Miami, IL
CEO
Marvin L. Slosman
Website
inspiremd.com
IPO
2011-04-12
CIK 1433607 ISIN US45779A8466
Description
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.72
+0.00 (+0.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
318.5K
Beta
0.78
Float Shares
27.09M
Free Float %
57.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.00% | +4.35% | -6.98% | -29.41% | -32.96% | -32.58% | -53.49% | -17.24% | -74.84% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
0.72
Low
3.00
+316.7%
Consensus
4.50
+525.1%
Median
4.50
+525.1%
High
6.00
+733.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
3.50
+386.2%
|
| Last Quarter | 3 |
4.00
+455.6%
|
| Last Year | 4 |
4.50
+525.1%
|
| All Time | 6 |
4.58
+536.2%
|
Quality scores
Altman Z-Score
-7.10
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+28.1% ★ Q1'26: +122.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+0.0% Q1'26: +101.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-535.4% Q1'26: -368.8% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-547.0% Q1'26: -411.4% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-1,528.1% Q1'26: -1,367.4% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+75.2% Q1'26: +47.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.05× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.31M
est: 2.59M (-10.9%)
|
1.89M
est: 3.86M (-51.0%)
|
2.76M
est: 7.90M (-65.1%)
|
3.60M
est: 66.40M (-94.6%)
|
3.72M
est: 4.30M (-13.5%)
|
2.49M
est: 3.50M (-29.0%)
|
4.50M
est: 4.50M (-0.1%)
|
5.17M
est: 5.00M (+3.4%)
|
6.21M
est: 6.48M (-4.2%)
|
7.01M
est: 6.90M (+1.6%)
|
8.98M
est: 8.45M (+6.3%)
|
10.38M
9.48M – 11.73M
+22.8% YoY
|
21.92M
20.03M – 24.78M
+111.2% YoY
|
| EBITDA |
-14.24M
est: -2.59M (-449.1%)
|
-7.55M
est: -3.86M (-95.4%)
|
-8.11M
est: -7.90M (-2.7%)
|
-7.46M
est: -66.40M (+88.8%)
|
-9.66M
est: -4.30M (-124.6%)
|
-10.23M
est: -3.50M (-192.3%)
|
-14.56M
est: -4.50M (-223.4%)
|
-18.53M
est: -5.00M (-270.5%)
|
-20.91M
est: -6.48M (-222.9%)
|
-33.22M
est: -6.90M (-381.7%)
|
-48.64M
est: -8.45M (-475.8%)
|
-10.38M
-11.73M – -9.48M
-22.8% YoY
|
-21.92M
-24.78M – -20.03M
-111.2% YoY
|
| EBIT |
-14.49M
est: -2.59M (-458.4%)
|
-7.74M
est: -3.86M (-100.3%)
|
-8.29M
est: -7.90M (-5.0%)
|
-7.61M
est: -66.40M (+88.5%)
|
-9.82M
est: -4.30M (-128.3%)
|
-10.38M
est: -3.50M (-196.6%)
|
-14.72M
est: -4.50M (-227.0%)
|
-18.71M
est: -5.00M (-274.3%)
|
-21.14M
est: -6.48M (-226.4%)
|
-33.50M
est: -6.90M (-385.8%)
|
-49.11M
est: -8.45M (-481.4%)
|
-10.38M
-11.73M – -9.48M
-22.8% YoY
|
-21.92M
-24.78M – -20.03M
-111.2% YoY
|
| Net Income |
-15.59M
est: -64.11T (+100.0%)
|
-8.46M
est: -16.78T (+100.0%)
|
-8.44M
est: -9.91T (+100.0%)
|
-7.24M
est: 68.79T (-100.0%)
|
-10.04M
est: -3.54B (+99.7%)
|
-10.54M
est: -251.57M (+95.8%)
|
-14.92M
est: -96.43M (+84.5%)
|
-18.49M
est: -108.59M (+83.0%)
|
-19.92M
|
-32.01M
est: -58.96M (+45.7%)
|
-48.79M
est: -62.99M (+22.5%)
|
-55.93M
-63.59M – -48.28M
+11.2% YoY
|
-44.81M
-52.42M – -39.79M
+19.9% YoY
|
| SGA |
9.57M
est: 6.95M (+37.7%)
|
6.46M
est: 10.35M (-37.6%)
|
7.54M
est: 21.16M (-64.4%)
|
7.07M
est: 177.85M (-96.0%)
|
7.62M
est: 11.52M (-33.9%)
|
8.23M
est: 9.37M (-12.2%)
|
10.31M
est: 12.05M (-14.4%)
|
12.02M
est: 13.39M (-10.2%)
|
14.97M
est: 18.43M (-18.8%)
|
21.38M
est: 19.63M (+8.9%)
|
37.26M
est: 24.04M (+55.0%)
|
29.53M
26.98M – 33.38M
+22.8% YoY
|
62.37M
57.00M – 70.51M
+111.2% YoY
|
| EPS |
-1,416,818.18
est: -1,529,062.00 (+7.3%)
|
-151,089.29
est: -400,312.00 (+62.3%)
|
-4,265.93
est: -236,250.00 (+98.2%)
|
-247.50
est: 1,640,625.00 (-100.0%)
|
-72.00
est: -84.45 (+14.7%)
|
-6.90
est: -6.00 (-15.0%)
|
-2.03
est: -2.30 (+11.7%)
|
-2.35
est: -2.59 (+9.3%)
|
-0.82
|
-0.76
est: -0.78 (+2.6%)
|
-0.76
est: -0.83 (+8.8%)
|
-0.74
-0.87 – -0.66
+11.2% YoY
|
-0.61
-0.71 – -0.54
+17.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Piper Sandler | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-35.68M
OE per share TTM
-0.60
Owner's Yield
-38.85%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
55.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
8
Total invested
599.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
36
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Rosalind Master Fund L.P. | 7.62M | 9.90% | — | 7.62M | — | 7.62M | PN | CAYMAN ISLANDS | 2023-06-08 | ↗ |
| 2 | Guy Levy | 2.20M | 9.90% | — | 2.20M | — | 2.20M | IN | Delaware | 2023-05-24 | ↗ |
| 3 | Soleus PE GP III, LLC | 2.20M | 9.90% | — | 2.20M | — | 2.20M | OO | Delaware | 2023-05-24 | ↗ |
| 4 | Soleus Private Equity Fund III, L.P. | 2.20M | 9.90% | — | 2.20M | — | 2.20M | PN | Delaware | 2023-05-24 | ↗ |
| 5 | Soleus Private Equity GP III, LLC | 2.20M | 9.90% | — | 2.20M | — | 2.20M | OO | Delaware | 2023-05-24 | ↗ |
| 6 | Daniel Mack | 2.16M | 9.90% | — | 2.16M | — | — | HC | USA | 2024-02-14 | ↗ |
| 7 | Nantahala Capital Management, LLC | 2.16M | 9.90% | — | 2.16M | — | — | IA | MA | 2024-02-14 | ↗ |
| 8 | Wilmot B. Harkey | 2.16M | 9.90% | — | 2.16M | — | — | HC | USA | 2024-02-14 | ↗ |
| 9 | OrbiMed Advisors LLC | 2.13M | 9.90% | — | 2.13M | — | — | IA | Delaware | 2024-02-14 | ↗ |
| 10 | OrbiMed Capital GP IX LLC | 1.88M | 8.70% | — | 1.88M | — | — | OO | Delaware | 2024-02-14 | ↗ |
| 11 | MW XO Health Innovations Fund, LP. | 1.86M | 9.90% | — | 1.86M | — | — | PN | Delaware | 2023-05-22 | ↗ |
| 12 | Marshall Wace North America L.P. | 1.86M | 9.90% | — | 1.86M | — | — | IA, PN | Delaware | 2023-05-22 | ↗ |
| 13 | Craig Shore | 1.70M | 8.01% | 663.8K | 1.04M | 663.8K | 1.04M | IN | — | 2023-06-16 | ↗ |
| 14 | Daniel B. Asher | 1.45M | 3.80% | — | 1.45M | — | 1.45M | HC, IN | United States of America | 2021-01-29 | ↗ |
| 15 | Intracoastal Capital LLC | 1.45M | 3.80% | — | 1.45M | — | 1.45M | OO | United States of America | 2021-01-29 | ↗ |
| 16 | Mitchell P. Kopin | 1.45M | 3.80% | — | 1.45M | — | 1.45M | HC, IN | United States of America | 2021-01-29 | ↗ |
| 17 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1.41M | 5.22% | — | 1.41M | — | — | PN | MA | 2024-12-04 | ↗ |
| 18 | Rosalind Opportunities Fund I L.P. | 1.37M | 5.40% | — | 1.37M | — | 1.37M | PN | ONTARIO, CANADA | 2023-06-08 | ↗ |
| 19 | L1 Capital Global Opportunities Master Fund Ltd. | 654.3K | 4.99% | 654.3K | — | — | — | FI | Cayman Islands | 2020-06-19 | ↗ |
| 20 | Steven Salamon | 394.7K | 9.90% | — | 394.7K | — | — | IN | ONTARIO, CANADA | 2023-06-08 | ↗ |
| 21 | Jeff Easton | 177.3K | 2.10% | 177.3K | — | 177.3K | — | IN | United States | 2022-02-11 | ↗ |
| 22 | Lind Global Macro Fund, LP | 177.3K | 2.10% | 177.3K | — | 177.3K | — | PN | Delaware | 2022-02-11 | ↗ |
| 23 | Lind Global Partners LLC | 177.3K | 2.10% | 177.3K | — | 177.3K | — | OO | Delaware | 2022-02-11 | ↗ |
| 24 | Armistice Capital Master Fund Ltd. | 101.7K | 4.99% | — | 101.7K | — | 101.7K | CO | Delaware | 2019-09-27 | ↗ |
| 25 | Armistice Capital, LLC | 101.7K | 4.99% | — | 101.7K | — | 101.7K | IA, OO | Delaware | 2019-09-27 | ↗ |
| 26 | Steven Boyd | 101.7K | 4.99% | — | 101.7K | — | 101.7K | HC, IN | Delaware | 2019-09-27 | ↗ |
| 27 | Michael Bigger | 37.0K | 1.00% | — | — | — | 37.0K | IN | Delaware | 2020-02-05 | ↗ |
| 28 | Bigger Capital Fund GP, LLC | 30.3K | 1.00% | — | — | — | 30.3K | OO | Delaware | 2020-02-05 | ↗ |
| 29 | Bigger Capital Fund, LP | 30.3K | 1.00% | — | — | — | 30.3K | PN | Delaware | 2020-02-05 | ↗ |
| 30 | CVI Investments, Inc. | 10.0K | 0.30% | — | 10.0K | — | 10.0K | CO | Cayman Islands | 2020-02-10 | ↗ |
| 31 | Heights Capital Management, Inc. | 10.0K | 0.30% | — | 10.0K | — | 10.0K | CO | Delaware | 2020-02-10 | ↗ |
| 32 | Patricia Winter | 6.7K | 1.00% | — | — | 6.7K | — | IN | Delaware | 2020-02-05 | ↗ |
| 33 | Empery Asset Management, LP | — | 0.00% | — | — | — | — | PN | Delaware | 2020-01-21 | ↗ |
| 34 | Empery Tax Efficient II, LP | — | 0.00% | — | — | — | — | PN | Delaware | 2020-01-21 | ↗ |
| 35 | Martin D. Hoe | — | 0.00% | — | — | — | — | IN | United States | 2020-01-21 | ↗ |
| 36 | Ryan M. Lane | — | 0.00% | — | — | — | — | IN | United States | 2020-01-21 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
8
-36 vs prev Q
New positions
1
Closed positions
37
Increased
2
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ROSALIND ADVISORS, INC. | 3.91M +— (+0.0%) | 6.95M -2.5M (-26.1%) | 5.32% -2.341 pp | 2.44% -0.774 pp | USD2.49 -28.5% | 9 qtrs — |
| 2 | NANTAHALA CAPITAL MANAGEMENT, LLC | 3.38M +— (+0.0%) | 6.01M -2.1M (-26.1%) | 4.60% -2.024 pp | 0.20% -0.084 pp | USD2.54 -29.9% | 11 qtrs — |
| 3 | ABRDN PLC | 3.17M +692.2K (+27.9%) | 5.65M -330.9K (-5.5%) | 4.32% -0.545 pp | 0.01% -0.001 pp | USD2.27 -21.6% | 2 qtrs — |
| 4 | ORBIMED ADVISORS LLC | 3.13M +1.0M (+46.9%) | 5.58M +436.0K (+8.5%) | 4.27% +0.082 pp | 0.11% -0.007 pp | USD2.30 -22.6% | 11 qtrs — |
| 5 | PARKMAN HEALTHCARE PARTNERS LLC | 2.42M -24.1K (-1.0%) | 4.30M -1.6M (-26.9%) | 3.29% -1.496 pp | 0.41% -0.204 pp | USD2.52 -29.4% | 6 qtrs — |
| 6 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 2.14M +— (+0.0%) | 3.82M -1.4M (-26.1%) | 2.92% -1.285 pp | 2.21% -2.639 pp | USD2.45 -27.3% | 11 qtrs — |
| 7 | MARSHALL WACE, LLP | 1.86M +— (+0.0%) | 3.31M -1.2M (-26.1%) | 2.53% -1.115 pp | 0.00% -0.002 pp | USD2.51 -29.1% | 11 qtrs — |
| 8 | SOLEUS CAPITAL MANAGEMENT, L.P. | 1.15M -320.9K (-21.8%) | 2.05M -1.5M (-42.3%) | 1.57% -1.319 pp | 0.08% -0.103 pp | USD2.39 -25.5% | 11 qtrs — |
| 9 | PURA VIDA INVESTMENTS, LLC | 450.5K +— (+0.0%) | 801.9K -283.8K (-26.1%) | 0.61% -0.270 pp | 3.00% -3.618 pp | USD3.08 -42.2% | 11 qtrs — |
| 10 | INGALLS & SNYDER LLC | 384.3K +159.3K (+70.8%) | 684.0K +142.0K (+26.2%) | 0.52% +0.082 pp | 0.03% +0.007 pp | USD2.15 -17.2% | 2 qtrs — |
| 11 | AFFIANCE FINANCIAL, LLC | 250.4K +— (+0.0%) | 445.7K -157.7K (-26.1%) | 0.34% -0.150 pp | 0.07% -0.038 pp | USD2.61 -31.8% | 6 qtrs — |
| 12 | CITADEL ADVISORS LLC | 193.7K +155.8K (+410.4%) | 344.8K +253.3K (+277.0%) | 0.26% +0.189 pp | 0.00% +0.000 pp | USD1.88 -5.3% | 3 qtrs — |
| 13 | MILLENNIUM MANAGEMENT LLC | 124.1K -23.3K (-15.8%) | 220.9K -134.4K (-37.8%) | 0.17% -0.120 pp | 0.00% 0.000 pp | USD2.47 -27.9% | 12 qtrs — |
| 14 | ESSEX INVESTMENT MANAGEMENT CO LLC | 114.1K +114.1K (+100.0%) | 203.1K +203.1K (+100.0%) | 0.16% +0.155 pp | 0.03% +0.031 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 15 | BLACKROCK, INC. | 60.9K +7.2K (+13.4%) | 108.4K -21.1K (-16.3%) | 0.08% -0.022 pp | 0.00% +0.000 pp | USD2.25 -20.9% | 3 qtrs — |
| 16 | COURIER CAPITAL LLC | 55.0K +— (+0.0%) | 97.9K -34.7K (-26.1%) | 0.07% -0.033 pp | 0.01% -0.002 pp | USD2.56 -30.5% | 4 qtrs — |
| 17 | MORGAN STANLEY | 41.8K -44.2K (-51.4%) | 74.5K -132.8K (-64.1%) | 0.06% -0.112 pp | 0.00% +0.000 pp | USD2.66 -33.1% | 11 qtrs — |
| 18 | VESTIA PERSONAL WEALTH ADVISORS | 42.4K +— (+0.0%) | 68.7K -33.5K (-32.8%) | 0.06% -0.025 pp | 0.03% -0.024 pp | USD2.35 -24.3% | 3 qtrs — |
| 19 | NORTHERN TRUST CORP | 33.6K +— (+0.0%) | 59.8K -21.2K (-26.1%) | 0.05% -0.020 pp | 0.00% +0.000 pp | USD2.71 -34.3% | 9 qtrs — |
| 20 | COMMONWEALTH EQUITY SERVICES, LLC | 32.6K +— (+0.0%) | 57.9K -20.1K (-25.7%) | 0.04% -0.020 pp | 0.00% +0.000 pp | USD2.41 -26.1% | 2 qtrs — |
| 21 | LEGATO CAPITAL MANAGEMENT LLC | 26.9K +26.9K (+100.0%) | 47.8K +47.8K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.004 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 22 | SCHONFELD STRATEGIC ADVISORS LLC | 23.3K -62.8K (-72.9%) | 41.5K -165.9K (-80.0%) | 0.03% -0.137 pp | 0.00% -0.001 pp | USD2.50 -28.8% | 6 qtrs — |
| 23 | CREATIVE PLANNING | 19.7K +145.0 (+0.7%) | 35.1K -12.1K (-25.6%) | 0.03% -0.012 pp | 0.00% +0.000 pp | USD2.27 -21.6% | 3 qtrs — |
| 24 | GEODE CAPITAL MANAGEMENT, LLC | 18.2K +— (+0.0%) | 32.5K -11.5K (-26.1%) | 0.02% -0.011 pp | 0.00% +0.000 pp | USD3.91 -54.5% | 18 qtrs — |
| 25 | VIRTU FINANCIAL LLC | 17.7K +17.7K (+100.0%) | 31.0K +31.0K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.001 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 26 | XTX TOPCO LTD | 17.0K +17.0K (+100.0%) | 30.3K +30.3K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.001 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 27 | AVESTAR CAPITAL, LLC | 15.0K +— (+0.0%) | 26.7K -9.5K (-26.1%) | 0.02% -0.009 pp | 0.00% -0.001 pp | USD3.27 -45.6% | 10 qtrs — |
| 28 | GOLDMAN SACHS GROUP INC | 12.9K +12.9K (+100.0%) | 23.0K +23.0K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 29 | TWO SIGMA SECURITIES, LLC | 11.8K +11.8K (+100.0%) | 21.0K +21.0K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.003 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 30 | PALLAS CAPITAL ADVISORS LLC | 11.0K +— (+0.0%) | 19.6K -6.9K (-26.1%) | 0.02% -0.007 pp | 0.00% 0.000 pp | USD2.41 -26.1% | 2 qtrs — |
| 31 | BROWN ADVISORY INC | 10.0K +— (+0.0%) | 17.8K -6.3K (-26.1%) | 0.01% -0.006 pp | 0.00% +0.000 pp | USD2.69 -33.8% | 4 qtrs — |
| 32 | MCKINLEY CARTER WEALTH SERVICES, INC. | 10.0K +— (+0.0%) | 17.8K -6.3K (-26.1%) | 0.01% -0.006 pp | 0.00% 0.000 pp | USD2.81 -36.7% | 9 qtrs — |
| 33 | HRT FINANCIAL LP | 10.1K +10.1K (+100.0%) | 17.0K +17.0K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 34 | ADVISORNET FINANCIAL, INC | 8.8K +— (+0.0%) | 15.6K -5.5K (-26.1%) | 0.01% -0.005 pp | 0.00% 0.000 pp | USD2.51 -29.1% | 11 qtrs — |
| 35 | ADVISOR GROUP HOLDINGS, INC. | 5.5K +5.5K (+100.0%) | 9.7K +9.7K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 36 | GROUP ONE TRADING, L.P. | 4.0K +— (+0.0%) | 7.1K -2.5K (-26.1%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD2.41 -26.1% | 2 qtrs — |
| 37 | SIMPLEX TRADING, LLC | 3.2K +2.7K (+587.2%) | 5.7K +4.7K (+465.1%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD1.87 -4.8% | 2 qtrs — |
| 38 | BELLEVUE ASSET MANAGEMENT, LLC | 25.00 +— (+0.0%) | 2.3K +450.0 (+24.3%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD3.64 -51.1% | 19 qtrs — |
| 39 | FARTHER FINANCE ADVISORS, LLC | 1.0K +— (+0.0%) | 1.8K -630.0 (-26.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.44 -27.0% | 7 qtrs — |
| 40 | BANK OF AMERICA CORP /DE/ | 113.00 -495.0 (-81.4%) | 201.00 -1.3K (-86.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.41 -26.1% | 2 qtrs — |
| 41 | UBS GROUP AG | 32.00 +32.0 (+100.0%) | 57.00 +57.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.75 +1.7% | 3 qtrs — |
| 42 | GLOBAL RETIREMENT PARTNERS, LLC | 27.00 +— (+0.0%) | 48.00 -17.0 (-26.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.26 -21.2% | 3 qtrs — |
| 43 | JONES FINANCIAL COMPANIES LLLP | 27.00 +27.0 (+100.0%) | 48.00 +48.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.78 +0.0% | 1 qtrs NEW |
| 44 | CITIGROUP INC | 1.00 +1.0 (+100.0%) | 2.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +78.0% | 1 qtrs NEW |
| 45 | UNITING WEALTH PARTNERS, LLC | — -21.1K (-100.0%) | — -50.8K (-100.0%) | 0.00% -0.041 pp | 0.00% -0.012 pp | USD— | 4 qtrs SOLD |
| 46 | HUNTLEIGH ADVISORS, INC. | — -264.0K (-100.0%) | — -636.3K (-100.0%) | 0.00% -0.518 pp | 0.00% -0.109 pp | USD— | 4 qtrs SOLD |
| 47 | IRONWOOD INVESTMENT MANAGEMENT LLC | — -61.6K (-100.0%) | — -148.4K (-100.0%) | 0.00% -0.121 pp | 0.00% -0.065 pp | USD— | 3 qtrs SOLD |
| 48 | KOESTEN, HIRSCHMANN & CRABTREE, INC. | — -2.0 (-100.0%) | — -5.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 49 | SBI SECURITIES CO., LTD. | — -230.0 (-100.0%) | — -554.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 50 | GHISALLO CAPITAL MANAGEMENT LLC | — -921.6K (-100.0%) | — -2.2M (-100.0%) | 0.00% -1.807 pp | 0.00% -0.073 pp | USD— | 2 qtrs SOLD |
| 51 | HOLLENCREST CAPITAL MANAGEMENT | — -20.0K (-100.0%) | — -48.2K (-100.0%) | 0.00% -0.039 pp | 0.00% -0.002 pp | USD— | 19 qtrs SOLD |
| 52 | MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | — -30.0K (-100.0%) | — -72.3K (-100.0%) | 0.00% -0.059 pp | 0.00% -0.001 pp | USD— | 9 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 82.7K | 0.60% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
10
Sells
10
Shares acquired
2.51M
Shares disposed
61.2K
Cash buys
—
Cash sales
10.00
Net activity
+2,444,673
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 2,000 | 1.60 | 3.2K | 1,139,177 | D | ↗ |
| 2026-01-30 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 2,900 | 1.63 | 4.7K | 1,141,177 | D | ↗ |
| 2026-01-29 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 5,000 | 1.65 | 8.3K | 1,144,077 | D | ↗ |
| 2026-01-28 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 12,395 | 1.65 | 20.5K | 1,149,077 | D | ↗ |
| 2026-01-27 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 4,781 | 1.66 | 8.0K | 1,161,472 | D | ↗ |
| 2026-01-22 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 8,411 | 1.57 | 13.2K | 1,166,253 | D | ↗ |
| 2026-01-21 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 17,593 | 1.62 | 28.6K | 1,174,664 | D | ↗ |
| 2026-01-20 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 2,955 | 1.59 | 4.7K | 1,192,257 | D | ↗ |
| 2026-01-16 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 2,250 | 1.61 | 3.6K | 1,195,212 | D | ↗ |
| 2026-01-15 | Gleason Shane Thomas | Officer | S-Sale | D | Common Stock | 2,909 | 1.58 | 4.6K | 1,197,462 | D | ↗ |
| 2026-01-14 | Ward Scott R. | Director | A-Award | A | Common Stock | 88,053 | 0.00 | — | 147,846 | D | ↗ |
| 2026-01-14 | Tommasoli Andrea | Officer | A-Award | A | Common Stock | 226,695 | 0.00 | — | 954,389 | D | ↗ |
| 2026-01-14 | Stuka Paul | Director | A-Award | A | Common Stock | 132,076 | 0.00 | — | 523,704 | D | ↗ |
| 2026-01-14 | Slosman Marvin | Director / Officer | A-Award | A | Restricted Stock Units | 1,114,792 | 0.00 | — | 3,535,658 | D | ↗ |
| 2026-01-14 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 88,053 | 0.00 | — | 744,478 | D | ↗ |
| 2026-01-14 | Lawless Michael A | Officer | A-Award | A | Common Stock | 226,695 | 0.00 | — | 691,695 | D | ↗ |
| 2026-01-14 | Gleason Shane Thomas | Officer | A-Award | A | Common Stock | 453,390 | 0.00 | — | 1,200,371 | D | ↗ |
| 2026-01-14 | Dearen Danny L. | Director | A-Award | A | Common Stock | 44,030 | 0.00 | — | 102,047 | D | ↗ |
| 2026-01-14 | COHEN RAYMOND W | Director | A-Award | A | Common Stock | 44,030 | 0.00 | — | 92,417 | D | ↗ |
| 2026-01-14 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 88,053 | 0.00 | — | 352,586 | D | ↗ |
| 2025-12-30 | Arnold Kathryn | Director | A-Award | A | Common Stock | 55,556 | 0.00 | — | 303,087 | D | ↗ |
| 2025-12-09 | Stuka Paul | Director | P-Purchase | A | Common Stock | 5,073 | 1.81 | 9.2K | 391,628 | D | ↗ |
| 2025-12-05 | Stuka Paul | Director | P-Purchase | A | Common Stock | 5,073 | 1.86 | 9.4K | 388,918 | D | ↗ |
| 2025-12-04 | Stuka Paul | Director | P-Purchase | A | Common Stock | 10,130 | 1.85 | 18.7K | 383,845 | D | ↗ |
| 2025-11-12 | Stuka Paul | Director | P-Purchase | A | Common Stock | 13,431 | 1.62 | 21.8K | 373,715 | D | ↗ |
| 2025-10-07 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 48,000 | 0.00 | — | 656,425 | D | ↗ |
| 2025-09-16 | Dearen Danny L. | Director | — | — | Common Stock | 0 | 0.00 | — | 58,017 | D | ↗ |
| 2025-09-15 | Kester Thomas J | Director | A-Award | A | Options to purchase common stock (right to buy) | 19,041 | 2.38 | 45.3K | 19,041 | D | ↗ |
| 2025-07-31 | COHEN RAYMOND W | Director | — | — | Common Stock | 0 | 0.00 | — | 48,387 | D | ↗ |
| 2025-07-30 | Stuka Paul | Director | P-Purchase | A | Common Stock | 20,661 | 2.42 | 50.0K | 444,195 | I | ↗ |
| 2025-07-30 | Slosman Marvin | Director / Officer | P-Purchase | A | Common Stock | 10,330 | 2.42 | 25.0K | 2,420,866 | D | ↗ |
| 2025-07-30 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 41,322 | 2.42 | 100.0K | 608,425 | D | ↗ |
| 2025-07-30 | Kester Thomas J | Director | P-Purchase | A | Common Stock | 30,991 | 2.42 | 75.0K | 420,758 | D | ↗ |
| 2025-07-11 | Kester Thomas J | Director | X-InTheMoney | A | Common Stock | 30,624 | 1.38 | 42.3K | 389,767 | D | ↗ |
| 2025-07-01 | Stuka Paul | Director | X-InTheMoney | A | Common Stock | 87,500 | 1.38 | 121.0K | 423,534 | I | ↗ |
| 2025-06-29 | BERMAN MICHAEL | Director | X-InTheMoney | D | Series I Warrant (right to buy) | 61,248 | 1.38 | 84.7K | 0 | I | ↗ |
| 2025-06-25 | ROUBIN GARY S | Director | X-InTheMoney | A | Common Stock | 30,624 | 1.38 | 42.3K | 567,103 | D | ↗ |
| 2025-06-25 | Lawless Michael A | Officer | — | — | Common Stock | 0 | 0.00 | — | 465,000 | D | ↗ |
| 2025-01-07 | Ward Scott R. | Director | A-Award | A | Common Stock | 16,245 | 0.00 | — | 59,793 | D | ↗ |
| 2025-01-07 | Verta Patrick | Officer | A-Award | A | Common Stock | 83,072 | 0.00 | — | 311,532 | D | ↗ |
| 2025-01-07 | Tommasoli Andrea | Officer | A-Award | A | Common Stock | 232,616 | 0.00 | — | 727,694 | D | ↗ |
| 2025-01-07 | Stuka Paul | Director | A-Award | A | Options to purchase common stock (right to buy) | 22,254 | 2.71 | 60.3K | 128,129 | D | ↗ |
| 2025-01-07 | Slosman Marvin | Director / Officer | A-Award | A | Options to purchase common stock (right to buy) | 254,985 | 2.71 | 691.0K | 937,796 | D | ↗ |
| 2025-01-07 | Shore Craig | Officer | A-Award | A | Common Stock | 232,616 | 0.00 | — | 1,112,460 | D | ↗ |
| 2025-01-07 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 32,491 | 0.00 | — | 534,279 | D | ↗ |
| 2025-01-07 | Kester Thomas J | Director | A-Award | A | Common Stock | 32,491 | 0.00 | — | 359,143 | D | ↗ |
| 2025-01-07 | Gleason Shane Thomas | Officer | A-Award | A | Options to purchase common stock (right to buy) | 106,218 | 2.71 | 287.9K | 289,346 | D | ↗ |
| 2025-01-07 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 32,491 | 0.00 | — | 264,533 | D | ↗ |
| 2025-01-07 | Arnold Kathryn | Director | A-Award | A | Common Stock | 32,491 | 0.00 | — | 247,531 | D | ↗ |
| 2024-11-25 | Ward Scott R. | Director | — | — | Common Stock | 0 | 0.00 | — | 43,548 | D | ↗ |
| 2024-06-24 | BERMAN MICHAEL | Director | X-InTheMoney | A | Common Stock | 61,249 | 1.38 | 84.7K | 183,746 | — | ↗ |
| 2024-06-05 | Stuka Paul | Director | X-InTheMoney | D | Series H Warrant (right to buy) | 87,500 | 1.38 | 121.0K | 0 | — | ↗ |
| 2024-05-28 | ROUBIN GARY S | Director | X-InTheMoney | D | Series H Warrant (right to buy) | 30,625 | 1.38 | 42.3K | 0 | — | ↗ |
| 2024-05-28 | Kester Thomas J | Director | X-InTheMoney | A | Common Stock | 30,625 | 1.38 | 42.3K | 326,652 | — | ↗ |
| 2024-01-23 | Verta Patrick | Officer | A-Award | A | Options to purchase common stock (right to buy) | 32,768 | 3.14 | 102.9K | 79,348 | — | ↗ |
| 2024-01-23 | Tommasoli Andrea | Officer | A-Award | A | Options to purchase common stock (right to buy) | 91,218 | 3.14 | 286.4K | 176,699 | — | ↗ |
| 2024-01-23 | Stuka Paul | Director | A-Award | A | Options to purchase common stock (right to buy) | 16,647 | 3.14 | 52.3K | 105,875 | — | ↗ |
| 2024-01-23 | Slosman Marvin | Director / Officer | A-Award | A | Options to purchase common stock (right to buy) | 215,405 | 3.14 | 676.4K | 682,811 | — | ↗ |
| 2024-01-23 | Shore Craig | Officer | A-Award | A | Options to purchase common stock (right to buy) | 91,218 | 3.14 | 286.4K | 311,488 | — | ↗ |
| 2024-01-23 | ROUBIN GARY S | Director | A-Award | A | Options to purchase common stock (right to buy) | 11,098 | 3.14 | 34.8K | 76,907 | — | ↗ |
| 2024-01-23 | Kester Thomas J | Director | A-Award | A | Options to purchase common stock (right to buy) | 11,098 | 3.14 | 34.8K | 70,111 | — | ↗ |
| 2024-01-23 | Gleason Shane Thomas | Officer | A-Award | A | Common Stock | 238,625 | 0.00 | — | 514,365 | — | ↗ |
| 2024-01-23 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 29,032 | 0.00 | — | 232,042 | — | ↗ |
| 2024-01-23 | Arnold Kathryn | Director | A-Award | A | Options to purchase common stock (right to buy) | 11,098 | 3.14 | 34.8K | 70,109 | — | ↗ |
| 2024-01-02 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 3,229 | 0.00 | — | 442,131 | — | ↗ |
| 2024-01-02 | Kester Thomas J | Director | A-Award | A | Common Stock | 3,183 | 0.00 | — | 267,043 | — | ↗ |
| 2024-01-02 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 3,782 | 0.00 | — | 203,010 | — | ↗ |
| 2024-01-02 | Arnold Kathryn | Director | A-Award | A | Common Stock | 1,661 | 0.00 | — | 186,008 | — | ↗ |
| 2023-11-30 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 50,000 | 2.53 | 126.5K | 438,902 | — | ↗ |
| 2023-10-02 | Verta Patrick | Officer | — | D | Options to purchase common stock (right to buy) | 46,580 | 3.30 | 153.7K | 0 | — | ↗ |
| 2023-10-02 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 2,652 | 0.00 | — | 388,902 | — | ↗ |
| 2023-10-02 | Kester Thomas J | Director | A-Award | A | Common Stock | 2,614 | 0.00 | — | 263,860 | — | ↗ |
| 2023-10-02 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 3,106 | 0.00 | — | 199,228 | — | ↗ |
| 2023-10-02 | Arnold Kathryn | Director | A-Award | A | Common Stock | 1,364 | 0.00 | — | 184,347 | — | ↗ |
| 2023-08-28 | Gleason Shane Thomas | Officer | A-Award | A | Common Stock | 19,290 | 0.00 | — | 275,740 | — | ↗ |
| 2023-07-01 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 3,445 | 0.00 | — | 386,250 | — | ↗ |
| 2023-07-01 | Kester Thomas J | Director | A-Award | A | Common Stock | 3,396 | 0.00 | — | 261,246 | — | ↗ |
| 2023-07-01 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 4,351 | 0.00 | — | 196,122 | — | ↗ |
| 2023-07-01 | Arnold Kathryn | Director | A-Award | A | Common Stock | 1,772 | 0.00 | — | 182,983 | — | ↗ |
| 2023-05-17 | Tommasoli Andrea | Officer | A-Award | A | Options to purchase common stock (right to buy) | 59,690 | 1.76 | 105.1K | 85,481 | — | ↗ |
| 2023-05-17 | Stuka Paul | Director | A-Award | A | Common Stock | 225,680 | 0.00 | — | 268,000 | — | ↗ |
| 2023-05-17 | Slosman Marvin | Director / Officer | A-Award | A | Restricted Stock Units | 1,045,150 | 0.00 | — | 1,288,620 | — | ↗ |
| 2023-05-17 | Shore Craig | Officer | A-Award | A | Options to purchase common stock (right to buy) | 174,190 | 1.76 | 306.6K | 220,270 | — | ↗ |
| 2023-05-17 | ROUBIN GARY S | Director | A-Award | A | Options to purchase common stock (right to buy) | 49,750 | 1.76 | 87.6K | 65,809 | — | ↗ |
| 2023-05-17 | Kester Thomas J | Director | A-Award | A | Options to purchase common stock (right to buy) | 49,750 | 1.76 | 87.6K | 59,013 | — | ↗ |
| 2023-05-17 | Gleason Shane Thomas | Officer | A-Award | A | Options to purchase common stock (right to buy) | 85,480 | 1.76 | 150.4K | 85,480 | — | ↗ |
| 2023-05-17 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 149,260 | 0.00 | — | 192,087 | — | ↗ |
| 2023-05-17 | Arnold Kathryn | Director | A-Award | A | Options to purchase common stock (right to buy) | 49,750 | 1.76 | 87.6K | 59,011 | — | ↗ |
| 2023-05-12 | Stuka Paul | Director | P-Purchase | A | Series I Warrants to purchase Common Stock | 87,500 | 1.38 | 121.0K | 87,500 | — | ↗ |
| 2023-05-12 | ROUBIN GARY S | Director | P-Purchase | A | Series I Warrants to purchase Common Stock | 30,624 | 1.38 | 42.3K | 30,624 | — | ↗ |
| 2023-05-12 | Kester Thomas J | Director | P-Purchase | A | Series K Warrants to purchase Common Stock | 30,624 | 1.38 | 42.3K | 30,624 | — | ↗ |
| 2023-05-12 | BERMAN MICHAEL | Director | P-Purchase | A | Series K Warrants to purchase Common Stock | 61,248 | 1.38 | 84.7K | 61,248 | — | ↗ |
| 2023-04-01 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 8,102 | 0.00 | — | 172,296 | — | ↗ |
| 2023-04-01 | Kester Thomas J | Director | A-Award | A | Common Stock | 7,986 | 0.00 | — | 47,341 | — | ↗ |
| 2023-04-01 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 9,491 | 0.00 | — | 42,827 | — | ↗ |
| 2023-04-01 | Arnold Kathryn | Director | A-Award | A | Common Stock | 4,167 | 0.00 | — | 31,951 | — | ↗ |
| 2023-03-19 | Tommasoli Andrea | Officer | — | D | Common Stock | 0 | 0.00 | — | 18,103 | — | ↗ |
| 2023-03-01 | Gleason Shane Thomas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-18 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 35,500 | 1.91 | 67.8K | 164,194 | — | ↗ |
| 2021-12-28 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 16,393 | 3.08 | 50.4K | 128,694 | — | ↗ |
| 2021-12-01 | Stuka Paul | Director | P-Purchase | A | Common Stock | 12,037 | 3.51 | 42.3K | 73,534 | — | ↗ |
| 2021-11-30 | Stuka Paul | Director | P-Purchase | A | Common Stock | 18,372 | 3.55 | 65.2K | 61,497 | — | ↗ |
| 2021-11-29 | Stuka Paul | Director | P-Purchase | A | Common Stock | 3,177 | 3.55 | 11.3K | 43,125 | — | ↗ |
| 2021-11-26 | Stuka Paul | Director | P-Purchase | A | Common Stock | 1,200 | 3.55 | 4.3K | 39,948 | — | ↗ |
| 2021-11-24 | Stuka Paul | Director | P-Purchase | A | Common Stock | 18,328 | 3.55 | 65.1K | 38,748 | — | ↗ |
| 2021-11-23 | Stuka Paul | Director | P-Purchase | A | Common Stock | 1,204 | 3.55 | 4.3K | 20,420 | — | ↗ |
| 2021-11-22 | Stuka Paul | Director | P-Purchase | A | Common Stock | 19,188 | 3.54 | 67.9K | 19,216 | — | ↗ |
| 2021-11-17 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 290 | 3.77 | 1.1K | 112,301 | — | ↗ |
| 2021-11-10 | Shore Craig | Officer | A-Award | A | Options to purchase common stock (right to buy) | 24,326 | 4.09 | 99.5K | 24,326 | — | ↗ |
| 2021-11-10 | BERMAN MICHAEL | Director | A-Award | A | Options to purchase common stock (right to buy) | 5,749 | 4.09 | 23.5K | 5,749 | — | ↗ |
| 2021-10-13 | Stuka Paul | Director | A-Award | A | Common Stock | 26,079 | 0.00 | — | 42,320 | — | ↗ |
| 2021-10-13 | Slosman Marvin | Director / Officer | A-Award | A | Restricted Stock Units | 146,567 | 0.00 | — | 243,470 | — | ↗ |
| 2021-10-13 | Rogers Campbell | Director | A-Award | A | Common Stock | 17,248 | 0.00 | — | 27,960 | — | ↗ |
| 2021-10-13 | ROUBIN GARY S | Director | A-Award | A | Common Stock | 17,248 | 0.00 | — | 86,371 | — | ↗ |
| 2021-10-13 | Kester Thomas J | Director | A-Award | A | Common Stock | 17,248 | 0.00 | — | 39,355 | — | ↗ |
| 2021-10-13 | Arnold Kathryn | Director | A-Award | A | Common Stock | 17,248 | 0.00 | — | 27,784 | — | ↗ |
| 2021-08-25 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 22,249 | 4.19 | 93.2K | 69,123 | — | ↗ |
| 2021-05-10 | Arnold Kathryn | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-04-19 | Slosman Marvin | Director / Officer | A-Award | A | Option to Purchase Common Stock | 600,000 | 0.46 | 276.0K | 1,052,556 | — | ↗ |
| 2021-04-19 | Shore Craig | Officer | A-Award | A | Option to Purchase Common Stock | 100,000 | 0.46 | 46.0K | 326,289 | — | ↗ |
| 2021-04-19 | ROUBIN GARY S | Director | A-Award | A | Option to Purchase Common Stock | 75,000 | 0.46 | 34.5K | 154,650 | — | ↗ |
| 2021-02-08 | Slosman Marvin | Director / Officer | P-Purchase | A | Common Stock | 40,320 | 0.62 | 25.0K | 1,453,538 | — | ↗ |
| 2021-02-08 | ROUBIN GARY S | Director | P-Purchase | A | Common Stock | 241,930 | 0.62 | 150.0K | 703,103 | — | ↗ |
| 2021-02-08 | Kester Thomas J | Director | P-Purchase | A | Common Stock | 120,960 | 0.62 | 75.0K | 331,593 | — | ↗ |
| 2021-02-08 | BERMAN MICHAEL | Director | P-Purchase | A | Common Stock | 80,640 | 0.62 | 50.0K | 241,275 | — | ↗ |
| 2020-10-16 | ROUBIN GARY S | Director | P-Purchase | A | Warrants | 222,223 | 0.50 | 110.0K | 222,223 | — | ↗ |
| 2020-10-12 | ROUBIN GARY S | Director | — | D | Common Stock | 0 | 0.00 | — | 238,950 | — | ↗ |
| 2020-08-31 | Stuka Paul | Director | A-Award | A | Common Stock | 238,950 | 0.00 | — | 243,606 | — | ↗ |
| 2020-08-31 | Slosman Marvin | Director / Officer | A-Award | A | Options (right to buy) | 391,762 | 0.39 | 152.8K | 452,556 | — | ↗ |
| 2020-08-31 | Shore Craig | Officer | A-Award | A | Common Stock | 678,834 | 0.00 | — | 684,849 | — | ↗ |
| 2020-08-31 | Rogers Campbell | Director | A-Award | A | Common Stock | 158,033 | 0.00 | — | 160,635 | — | ↗ |
| 2020-08-31 | Kester Thomas J | Director | A-Award | A | Common Stock | 158,033 | 0.00 | — | 210,633 | — | ↗ |
| 2020-08-31 | BERMAN MICHAEL | Director | A-Award | A | Options to purchase common stock (right to buy) | 52,678 | 0.39 | 20.5K | 52,692 | — | ↗ |
| 2020-06-05 | Slosman Marvin | Director / Officer | P-Purchase | A | Warrants | 55,550 | 0.50 | 27.5K | 55,550 | — | ↗ |
| 2020-06-03 | Kester Thomas J | Director | P-Purchase | A | Common Stock | 50,000 | 0.42 | 20.8K | 52,600 | — | ↗ |
| 2020-01-02 | Slosman Marvin | Director / Officer | A-Award | A | Options (right to buy) | 60,794 | 1.10 | 66.9K | 60,794 | — | ↗ |
| 2020-01-01 | Slosman Marvin | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-12-16 | Barry James J | Director / Officer | A-Award | A | Common Stock | 165,000 | 0.00 | — | 2,166,382 | — | ↗ |
| 2019-02-04 | Stuka Paul | Director | A-Award | A | Common Stock | 195,000 | 0.00 | — | 219,999 | — | ↗ |
| 2019-02-04 | Shore Craig | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 300,523 | — | ↗ |
| 2019-02-04 | Rogers Campbell | Director | A-Award | A | Common Stock | 130,000 | 0.00 | — | 130,011 | — | ↗ |
| 2019-02-04 | Kester Thomas J | Director | A-Award | A | Common Stock | 130,000 | 0.00 | — | 130,000 | — | ↗ |
| 2019-02-04 | Barry James J | Director / Officer | A-Award | A | Common Stock | 2,000,000 | 0.00 | — | 2,001,382 | — | ↗ |
| 2019-02-04 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 130,000 | 0.00 | — | 130,005 | — | ↗ |
| 2018-12-11 | Stuka Paul | Director | S-Sale | D | Common Stock | 65 | 0.18 | 11.54 | 12,746 | — | ↗ |
| 2018-11-21 | Kester Thomas J | Director | S-Sale | D | Common Stock | 8 | 0.21 | 1.68 | 0 | — | ↗ |
| 2018-01-26 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 11 | 0.18 | 1.98 | 48,376 | — | ↗ |
| 2017-08-01 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 22,877 | 0.44 | 10.1K | 48,387 | — | ↗ |
| 2017-07-14 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 65 | 0.45 | 29.25 | 71,264 | — | ↗ |
| 2017-01-26 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 12 | 2.44 | 29.28 | 71,349 | — | ↗ |
| 2016-12-07 | Stuka Paul | Director | A-Award | A | Options (right to buy) | 12,500 | 3.04 | 38.0K | 12,500 | — | ↗ |
| 2016-12-07 | Rogers Campbell | Director | A-Award | A | Options (right to buy) | 12,500 | 3.04 | 38.0K | 12,500 | — | ↗ |
| 2016-12-07 | Kester Thomas J | Director | A-Award | A | Options to purchase common stock (right to buy) | 2,500 | 3.04 | 7.6K | 2,500 | — | ↗ |
| 2016-12-07 | BLECH ISAAC | Director | A-Award | A | Options to purchase Common Stock | 12,500 | 3.04 | 38.0K | 12,500 | — | ↗ |
| 2016-12-07 | BERMAN MICHAEL | Director | A-Award | A | Options (right to buy) | 12,500 | 3.04 | 38.0K | 12,500 | — | ↗ |
| 2016-12-07 | BARER SOL J | Director | A-Award | A | Options (right to buy) | 20,000 | 3.04 | 60.8K | 20,000 | — | ↗ |
| 2016-10-24 | GAGO AGUSTIN V | Officer | A-Award | A | Options to purchase common stock (right to buy) | 32,000 | 1.86 | 59.5K | 32,000 | — | ↗ |
| 2016-09-06 | Kester Thomas J | Director | A-Award | A | Options to purchase common stock (right to buy) | 250,000 | 0.13 | 32.5K | 250,000 | — | ↗ |
| 2016-08-01 | Barry James J | Director / Officer | A-Award | A | Common Stock | 1,762,478 | 0.00 | — | 1,783,496 | — | ↗ |
| 2016-07-25 | Shore Craig | Officer | A-Award | A | Common Stock | 440,619 | 0.00 | — | 455,981 | — | ↗ |
| 2016-07-25 | Barry James J | Director / Officer | A-Award | A | Options (right to buy) | 1,762,478 | 0.19 | 334.9K | 1,762,478 | — | ↗ |
| 2016-07-14 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 1,623 | 0.18 | 292.14 | 21,018 | — | ↗ |
| 2016-07-07 | Stuka Paul | Director | P-Purchase | A | Warrants to Purchase Common Stock | 151,500 | 0.20 | 30.3K | 151,500 | — | ↗ |
| 2016-07-07 | BARER SOL J | Director | P-Purchase | A | Warrants to Purchase Common Stock | 3,333,300 | 0.20 | 666.7K | 3,333,300 | — | ↗ |
| 2016-06-30 | Stuka Paul | Director | A-Award | A | Options (right to buy) | 136,257 | 0.33 | 45.0K | 136,257 | — | ↗ |
| 2016-06-30 | Rogers Campbell | Director | A-Award | A | Options (right to buy) | 94,332 | 0.33 | 31.1K | 94,332 | — | ↗ |
| 2016-06-30 | BLECH ISAAC | Director | A-Award | A | Options (right to buy) | 48,524 | 0.33 | 16.0K | 48,524 | — | ↗ |
| 2016-06-30 | BERMAN MICHAEL | Director | A-Award | A | Options (right to buy) | 111,800 | 0.33 | 36.9K | 111,800 | — | ↗ |
| 2016-06-30 | BARER SOL J | Director | A-Award | A | Options (right to buy) | 122,282 | 0.33 | 40.4K | 122,282 | — | ↗ |
| 2016-05-03 | BLECH ISAAC | Director | A-Award | A | Options to purchase Common Stock | 780,000 | 0.50 | 390.0K | 780,000 | — | ↗ |
| 2016-03-21 | Stuka Paul | Director | P-Purchase | A | Common Stock | 127,119 | 0.59 | 75.0K | 267,060 | — | ↗ |
| 2016-03-21 | Rogers Campbell | Director | P-Purchase | A | Warrants to Purchase Common Stock | 4,237 | 0.59 | 2.5K | 4,237 | — | ↗ |
| 2016-03-21 | LOUGHLIN JAMES J | Director | P-Purchase | A | Warrants to Purchase Common Stock | 25,000 | 0.59 | 14.8K | 25,000 | — | ↗ |
| 2016-03-21 | BARER SOL J | Director | P-Purchase | A | Warrants to Purchase Common Stock | 423,729 | 0.59 | 250.0K | 423,729 | — | ↗ |
| 2016-01-31 | MILINAZZO ALAN | Director / Officer | F-InKind | D | Common Stock | 1,081 | 0.56 | 605.36 | 158,718 | — | ↗ |
| 2016-01-29 | MILINAZZO ALAN | Director / Officer | F-InKind | D | Common Stock | 968 | 0.56 | 542.08 | 159,799 | — | ↗ |
| 2016-01-26 | Stuka Paul | Director | D-Return | D | Options (right to buy) | 5,000 | 31.00 | 155.0K | 0 | — | ↗ |
| 2016-01-26 | Shore Craig | Officer | A-Award | A | Common Stock | 1 | 0.00 | — | 15,362 | — | ↗ |
| 2016-01-26 | Rogers Campbell | Director | D-Return | D | Options (right to buy) | 5,409 | 7.20 | 38.9K | 0 | — | ↗ |
| 2016-01-26 | MILINAZZO ALAN | Director / Officer | D-Return | D | Options (right to buy) | 60,001 | 40.50 | 2.43M | 0 | — | ↗ |
| 2016-01-26 | LOUGHLIN JAMES J | Director | A-Award | A | Common Stock | 1 | 0.00 | — | 1,501 | — | ↗ |
| 2016-01-26 | Barry James J | Director / Officer | D-Return | D | Options (right to buy) | 5,000 | 31.00 | 155.0K | 0 | — | ↗ |
| 2016-01-26 | BERMAN MICHAEL | Director | A-Award | A | Common Stock | 1 | 0.00 | — | 3,001 | — | ↗ |
| 2016-01-26 | BARER SOL J | Director | A-Award | A | Common Stock | 1 | 0.00 | — | 294,232 | — | ↗ |
| 2016-01-22 | BLECH ISAAC | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-01-03 | MILINAZZO ALAN | Director / Officer | F-InKind | D | Common Stock | 4,982 | 0.88 | 4.4K | 1,458,185 | — | ↗ |
| 2015-12-31 | MILINAZZO ALAN | Director / Officer | F-InKind | D | Common Stock | 24,094 | 0.88 | 21.2K | 1,463,167 | — | ↗ |
| 2015-11-30 | Barry James J | Director / Officer | F-InKind | D | Common Stock | 1,625 | 2.70 | 4.4K | 381,148 | — | ↗ |
| 2015-09-30 | Stuka Paul | Director | A-Award | A | Options (right to buy) | 90,869 | 0.17 | 15.4K | 90,869 | — | ↗ |
| 2015-09-30 | Rogers Campbell | Director | A-Award | A | Options (right to buy) | 62,909 | 0.17 | 10.7K | 62,909 | — | ↗ |
| 2015-09-30 | LOUGHLIN JAMES J | Director | A-Award | A | Options (right to buy) | 95,528 | 0.17 | 16.2K | 95,528 | — | ↗ |
| 2015-09-30 | BERMAN MICHAEL | Director | A-Award | A | Options (right to buy) | 74,559 | 0.17 | 12.7K | 74,559 | — | ↗ |
| 2015-09-30 | BARER SOL J | Director | A-Award | A | Options (right to buy) | 81,549 | 0.17 | 13.9K | 81,549 | — | ↗ |
| 2015-06-30 | Stuka Paul | Director | A-Award | A | Option (right to buy) | 55,338 | 0.28 | 15.5K | 55,338 | — | ↗ |
| 2015-06-30 | Rogers Campbell | Director | A-Award | A | Option (right to buy) | 38,311 | 0.28 | 10.7K | 38,311 | — | ↗ |
| 2015-06-30 | LOUGHLIN JAMES J | Director | A-Award | A | Option (right to buy) | 58,176 | 0.28 | 16.3K | 58,176 | — | ↗ |
| 2015-06-30 | BERMAN MICHAEL | Director | A-Award | A | Option (right to buy) | 45,405 | 0.28 | 12.7K | 45,405 | — | ↗ |
| 2015-06-30 | BARER SOL J | Director | A-Award | A | Options (right to buy) | 49,662 | 0.28 | 13.9K | 49,662 | — | ↗ |
| 2015-05-05 | MILINAZZO ALAN | Director / Officer | F-InKind | D | Common Stock | 1,949 | 2.60 | 5.1K | 140,395 | — | ↗ |
| 2015-05-01 | Barry James J | Director / Officer | D-Return | D | Common Stock | 10,562 | 0.00 | — | 27,715 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-5.8K
Shares Outstanding
46.80M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Marvin Slosman President and Chief Executive Officer | 588.5K | 397.2K | 1.54M | 544.5K | — | 23.8K | 3.10M | 67.38% | ↗ |
| 2 | 2025 | Craig Shore Former Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer | 261.1K | 132.8K | 642.0K | 226.8K | — | 1.09M | 2.35M | 36.97% | ↗ |
| 3 | 2025 | Michael Lawless Chief Financial Officer, Secretary and Treasurer | 187.5K | 87.4K | 1.04M | 353.4K | — | 17.5K | 1.69M | 82.67% | ↗ |
| 4 | 2025 | Shane Gleason Chief Commercial Officer | 367.5K | 82.7K | 642.0K | 226.8K | — | 22.1K | 1.45M | 59.99% | ↗ |
| 5 | 2024 | Marvin Slosman President and Chief Executive Officer | 550.0K | 391.9K | 1.77M | 566.9K | — | 22.6K | 3.30M | 70.78% | ↗ |
| 6 | 2024 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 319.9K | 184.9K | 749.3K | 240.0K | — | 142.6K | 1.64M | 60.45% | ↗ |
| 7 | 2024 | Craig Shore Former Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer | 319.9K | 184.9K | 749.3K | 240.0K | — | 142.6K | 1.64M | 60.45% | ↗ |
| 8 | 2024 | Shane Gleason Chief Commercial Officer | 342.0K | 81.2K | 749.3K | 240.0K | — | 18.0K | 1.52M | 65.20% | ↗ |
| 9 | 2023 | Marvin Slosman President and Chief Executive Officer | 470.0K | 324.3K | 1.84M | 536.0K | — | 49.5K | 3.22M | 73.79% | ↗ |
| 10 | 2023 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 305.4K | 171.5K | 919.7K | 268.0K | — | 136.5K | 1.80M | 65.94% | ↗ |
| 11 | 2023 | Shane Gleason Chief Commercial Officer | 274.3K | 125.8K | 516.4K | 150.5K | — | 41.2K | 1.11M | 60.18% | ↗ |
| 12 | 2022 | Marvin Slosman President and Chief Executive Officer | 432.5K | 233.6K | — | — | — | 30.8K | 696.8K | 0.00% | ↗ |
| 13 | 2022 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 319.5K | 164.7K | — | — | — | 141.0K | 625.2K | 0.00% | ↗ |
| 14 | 2022 | Andrea Tommasoli Chief Operating Officer | 226.8K | 71.2K | — | — | — | 61.2K | 359.3K | 0.00% | ↗ |
| 15 | 2021 | Marvin Slosman President and Chief Executive Officer | 410.0K | 169.1K | 603.9K | 428.8K | — | 24.4K | 1.64M | 63.12% | ↗ |
| 16 | 2021 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 319.6K | 164.3K | 300.7K | 130.5K | — | 141.9K | 1.06M | 40.80% | ↗ |
| 17 | 2021 | Andrea Tommasoli Chief Operating Officer | 242.5K | 46.6K | 244.2K | 72.9K | — | 62.3K | 668.5K | 47.43% | ↗ |
| 18 | 2020 | Marvin Slosman President and Chief Executive Officer | 366.7K | 150.0K | 659.0K | 196.2K | — | 10.3K | 1.38M | 61.87% | ↗ |
| 19 | 2020 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 265.0K | 138.7K | 264.7K | 79.0K | — | 121.6K | 869.0K | 39.55% | ↗ |
| 20 | 2019 | James Barry, Ph.D. Former President and Chief Executive Officer | 454.4K | — | 141.9K | — | — | 607.3K | 1.20M | 11.79% | ↗ |
| 21 | 2019 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 269.8K | 60.0K | 57.0K | — | — | 114.4K | 501.2K | 11.37% | ↗ |
| 22 | 2018 | James Barry, Ph.D. President and Chief Executive Officer | 391.3K | 195.6K | — | — | — | 62.7K | 649.5K | 0.00% | ↗ |
| 23 | 2018 | James Barry, Ph.D. Former President and Chief Executive Officer | 391.3K | 195.6K | — | — | — | 62.7K | 649.5K | 0.00% | ↗ |
| 24 | 2018 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 267.3K | 77.0K | — | — | — | 119.1K | 463.4K | 0.00% | ↗ |
| 25 | 2018 | Agustin Gago Former Executive Vice President and Chief Commercial Officer | 258.0K | — | — | — | — | 171.8K | 429.7K | 0.00% | ↗ |
| 26 | 2017 | James Barry, Ph.D. President and Chief Executive Officer | 365.0K | 25.0K | — | — | — | 50.3K | 440.3K | 0.00% | ↗ |
| 27 | 2017 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 267.1K | 25.0K | — | — | — | 104.7K | 396.8K | 0.00% | ↗ |
| 28 | 2017 | Agustin Gago Executive Vice President And Chief Commercial Officer | 275.0K | 75.0K | — | — | — | 28.3K | 378.3K | 0.00% | ↗ |
| 29 | 2017 | Agustin Gago Former Executive Vice President and Chief Commercial Officer | 275.0K | 75.0K | — | — | — | 28.3K | 353.3K | 0.00% | ↗ |
| 30 | 2016 | James Barry, Ph.D. President and Chief Executive Officer | 289.0K | 106.5K | 334.9K | 235.8K | — | 25.8K | 991.9K | 57.53% | ↗ |
| 31 | 2016 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 290.3K | 50.0K | 83.7K | 60.7K | — | 95.3K | 580.1K | 24.90% | ↗ |
| 32 | 2016 | Alan Milinazzo Former President and Chief Executive Officer | 242.1K | — | — | — | — | 25.3K | 267.4K | 0.00% | ↗ |
| 33 | 2016 | Agustin Gago Executive Vice President And Chief Commercial Officer | 51.2K | 25.0K | — | 61.2K | — | — | 137.5K | 44.55% | ↗ |
| 34 | 2016 | Agustin Gago | 51.2K | 25.0K | — | 61.2K | — | — | 137.5K | 44.55% | ↗ |
| 35 | 2015 | Alan Milinazzo Former President and Chief Executive Officer | 225.0K | 45.8K | 428.8K | 131.2K | — | 20.5K | 851.3K | 65.78% | ↗ |
| 36 | 2015 | Alan Milinazzo President and Chief Executive Officer | 225.0K | 45.8K | 428.8K | 131.2K | — | 20.5K | 851.3K | 65.78% | ↗ |
| 37 | 2015 | James Barry, Ph.D. President and Chief Executive Officer | 300.3K | 37.5K | 127.2K | 16.7K | — | 19.9K | 532.1K | 27.05% | ↗ |
| 38 | 2015 | James Barry, Ph.D. Executive Vice President and Chief Operating Officer | 300.3K | 37.5K | 127.2K | 16.7K | — | 19.9K | 532.1K | 27.05% | ↗ |
| 39 | 2015 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 224.5K | 17.3K | 33.8K | 33.5K | — | 74.3K | 383.4K | 17.54% | ↗ |
| 40 | 2014 | Alan Milinazzo President and Chief Executive | 450.0K | 69.1K | 553.9K | 736.5K | — | 20.5K | 1.83M | 70.51% | ↗ |
| 41 | 2014 | Alan Milinazzo President and Chief Executive Officer | 450.0K | 69.1K | 553.9K | 736.5K | — | 20.5K | 1.83M | 70.51% | ↗ |
| 42 | 2014 | Rick Olson Vice President | 183.8K | 25.9K | 391.5K | 802.5K | — | 123.7K | 1.53M | 78.17% | ↗ |
| 43 | 2014 | James Barry, Ph.D. Executive Vice President and Chief Operating Officer | 183.8K | 25.9K | 391.5K | 802.5K | — | 123.7K | 1.53M | 78.17% | ↗ |
| 44 | 2014 | James Barry, Ph.D. Executive Vice President and Chief Operating | 214.5K | 22.3K | 327.0K | 322.8K | — | 59.3K | 946.0K | 68.70% | ↗ |
| 45 | 2014 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 214.5K | 22.3K | 327.0K | 322.8K | — | 59.3K | 946.0K | 68.70% | ↗ |
| 46 | 2013 | Alan Milinazzo President and Chief Executive Officer | 222.5K | — | 1.99M | 164.7K | — | 9.8K | 4.06M | 53.06% | ↗ |
| 47 | 2013 | Craig Shore Chief Financial Officer, Chief Administrative Officer, Secretary and | 222.5K | — | 1.99M | 1.84M | — | 9.8K | 4.06M | 94.28% | ↗ |
| 48 | 2013 | Alan Milinazzo President and Chief Executive | 225.0K | 275.0K | — | — | — | 11.8K | 511.8K | 0.00% | ↗ |
| 49 | 2013 | Ofir Paz Former Chief Executive Officer | 96.4K | — | — | — | — | 228.8K | 325.1K | 0.00% | ↗ |
| 50 | 2013 | Robert Ratini Vice President of Sales and Marketing of InspireMD Ltd. | — | — | — | — | — | 323.5K | 323.5K | 0.00% | ↗ |
| 51 | 2013 | Craig Shore Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer | 165.1K | — | — | 45.1K | — | 42.9K | 253.0K | 17.81% | ↗ |
| 52 | 2013 | Eli Bar Senior Vice President of Research and | 165.1K | — | — | 45.1K | — | 42.9K | 253.0K | 17.81% | ↗ |
| 53 | 2013 | James Barry, Ph.D. Executive Vice President and Chief Operating | 92.2K | 50.1K | — | — | — | 36.9K | 179.2K | 0.00% | ↗ |
| 54 | 2013 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 92.2K | 50.1K | 238.7K | 146.9K | — | 36.9K | 179.2K | 215.19% | ↗ |
| 55 | 2013 | Eli Bar Senior Vice President of Research and Development and Chief Technical Officer of InspireMD Ltd. | 92.2K | 44.2K | — | — | — | 36.7K | 173.0K | 0.00% | ↗ |
| 56 | 2013 | Rick Olson Vice President | 12.5K | — | — | — | — | — | 12.5K | 0.00% | ↗ |
| 57 | 2012 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 76.7K | — | — | 139.5K | — | 18.2K | 234.4K | 59.51% | ↗ |
| 58 | 2012 | Eli Bar Senior Vice President of Research and | 76.7K | — | — | 139.5K | — | 18.2K | 234.4K | 59.51% | ↗ |
| 59 | 2012 | Craig Shore Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer | 76.7K | — | — | 139.5K | — | 18.2K | 234.4K | 59.51% | ↗ |
| 60 | 2012 | Asher Holzer, Ph.D. Former President | 139.7K | — | — | — | — | 49.6K | 189.3K | 0.00% | ↗ |
| 61 | 2012 | Ofir Paz Former Chief Executive Officer | 121.3K | — | — | — | — | 32.3K | 153.6K | 0.00% | ↗ |
| 62 | 2012 | Ofir Paz Chief Executive Officer | 121.3K | — | — | — | — | 32.3K | 153.6K | 0.00% | ↗ |
| 63 | 2012 | Robert Ratini Vice President of Sales and Marketing of InspireMD Ltd. | — | — | — | 84.4K | — | 55.6K | 140.0K | 60.27% | ↗ |
| 64 | 2012 | Eli Bar Senior Vice President, Research and Development and Chief Technical Officer of InspireMD Ltd. | 77.1K | 12.9K | — | — | — | 22.5K | 112.4K | 0.00% | ↗ |
| 65 | 2012 | Eli Bar Senior Vice President of Research and Development and Chief Technical Officer of InspireMD Ltd. | 77.1K | 12.9K | — | — | — | 22.5K | 112.4K | 0.00% | ↗ |
| 66 | 2012 | Sara Paz Former Vice President of Sales of InspireMD Ltd. | — | — | — | — | — | 83.6K | 83.6K | 0.00% | ↗ |
| 67 | 2011 | Sara Paz Former Vice President of Sales of InspireMD Ltd. | — | — | — | — | — | 142.6K | 782.0K | 0.00% | ↗ |
| 68 | 2011 | Craig Shore Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer | 118.3K | — | — | 260.6K | — | 40.5K | 419.4K | 62.12% | ↗ |
| 69 | 2011 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 118.3K | — | — | 260.6K | — | 40.5K | 419.4K | 62.12% | ↗ |
| 70 | 2011 | Eli Bar Senior Vice President, Research and Development and Chief Technical Officer of InspireMD Ltd. | 122.8K | — | — | — | — | 42.5K | 350.4K | 0.00% | ↗ |
| 71 | 2011 | Eli Bar Senior Vice President of Research and Development and Chief Technical Officer of InspireMD Ltd. | 122.8K | — | — | 185.2K | — | 42.5K | 350.4K | 52.85% | ↗ |
| 72 | 2011 | Ofir Paz Chief Executive Officer | 57.8K | — | — | — | — | 189.2K | 247.0K | 0.00% | ↗ |
| 73 | 2011 | Ofir Paz Former Chief Executive Officer | 57.8K | — | — | — | — | 189.2K | 247.0K | 0.00% | ↗ |
| 74 | 2011 | Asher Holzer, Ph.D. Former President | 57.8K | — | — | — | — | 187.6K | 245.4K | 0.00% | ↗ |
| 75 | 2010 | Eli Bar Senior Vice President, Research and Development and Chief Technical Officer of InspireMD Ltd. | 91.7K | — | — | — | — | 32.5K | 942.7K | 0.00% | ↗ |
| 76 | 2010 | Eli Bar Vice President, Research and Development of InspireMD Ltd. | 111.7K | — | — | 818.5K | — | — | 930.2K | 88.00% | ↗ |
| 77 | 2010 | Ofir Paz Chief Executive Officer | 89.2K | — | — | — | — | 130.0K | 219.2K | 0.00% | ↗ |
| 78 | 2010 | Asher Holzer, Ph.D. Former President | 89.2K | — | — | — | — | 120.4K | 209.6K | 0.00% | ↗ |
| 79 | 2010 | Asher Holzer President and Chairman | 122.4K | — | — | — | — | 74.8K | 197.2K | 0.00% | ↗ |
| 80 | 2010 | Ofir Paz Chief Executive Officer | 118.7K | — | — | — | — | 78.5K | 197.2K | 0.00% | ↗ |
| 81 | 2010 | Sara Paz Former Vice President of Sales of InspireMD Ltd. | — | — | — | — | — | 77.6K | 77.6K | 0.00% | ↗ |
| 82 | 2010 | Craig Shore Chief Financial Officer, Secretary and Treasurer | 9.9K | — | — | — | — | 3.3K | 13.2K | 0.00% | ↗ |
| 83 | 2010 | Lynn Briggs Former President, CEO, CFO, Secretary and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 84 | 2009 | Ofir Paz Chief Executive Officer | 76.5K | — | — | — | — | 129.9K | 206.4K | 0.00% | ↗ |
| 85 | 2009 | Asher Holzer, Ph.D. Former President | 73.5K | — | — | — | — | 109.1K | 182.6K | 0.00% | ↗ |
| 86 | 2009 | Asher Holzer President and Chairman | 106.9K | — | — | — | — | 55.2K | 162.1K | 0.00% | ↗ |
| 87 | 2009 | Ofir Paz Chief Executive Officer | 104.3K | — | — | — | — | 57.8K | 162.1K | 0.00% | ↗ |
| 88 | 2009 | Eli Bar Senior Vice President, Research and Development and Chief Technical Officer of InspireMD Ltd. | 87.0K | — | — | — | — | 38.6K | 125.6K | 0.00% | ↗ |
| 89 | 2009 | Eli Bar Vice President, Research and Development of InspireMD Ltd. | 106.0K | — | — | — | — | — | 106.0K | 0.00% | ↗ |
| 90 | 2009 | Sara Paz Former Vice President of Sales of InspireMD Ltd. | — | — | — | — | — | 59.2K | 59.2K | 0.00% | ↗ |
| 91 | 2009 | Lynn Briggs Former President, CEO, CFO, Secretary and Treasurer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marvin L. Slosman | President, Chief Executive Officer & Director | 1M | male |
| Shane Thomas Gleason | Chief Commercial Officer | 579.5K | male |
| Michael A. Lawless | CFO, Secretary & Treasurer | 470.1K | male |
| Andrea Tommasoli | Chief Operating Officer | 359.3K | male |
| Sol J. Barer | Special Advisor to the Board | 13.9K | — |
| Pete Ligotti | Executive Vice President & GM of North America | — | male |
| Peter A. Soukas | Chief Medical Officer | — | — |
| Donna DeChant | Vice President of Human Resources & Organizational Development | — | female |
| Amir Kohen | Executive Vice President of Finance & Regional Manager | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NSPR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
